ACR 2024 Review Podcast

Key highlights from the ACR 2024 conference on immune-mediated inflammatory diseases are explored, with a focus on findings related to psoriatic arthritis. The potential of JAK inhibitors, like gazelcomab, is discussed alongside insights into the role of sex differences in medication responses. The impact of central nervous system factors on fatigue in inflammatory diseases is also examined. Emerging treatments like Sonolocumab and advancements in rheumatoid arthritis care are covered, while mental health outcomes related to bimicizumab treatment are analyzed.